Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

044IC - AUA Guidelines 2018: Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

Sunday, May 20
7:30 AM - 9:30 AM
Location: MCC WEST, 2004

This course will review the new AUA guidelines on lower urinary tract symptoms associated with benign prostatic hyperplasia or BPH/LUTS. Faculty will explore the rigorous process used in the development of these evidence based guidelines, as well as discuss future research needs. The course will provide a clinical framework for the diagnosis, evaluation, treatment and follow-up of patients with lower urinary tract symptoms associated with benign prostatic hyperplasia or BPH/LUTS based on the best available published literature. The course will showcase clinical scenarios in urological practice and the correct application of the new AUA guidelines in those instances. This course will be a benefit to practicing urologists, primary care providers, other non-physician providers, residents preparing for their re-certification exam and physicians preparing for their re-certification exam.

Learning Objectives:

Steven A. Kaplan

Icahn School of Medicine at Mount Sinai

Dr. Steven Kaplan graduated from Mount Sinai School of Medicine in 1982 and was elected to the AOA Honor Society. Dr. Kaplan’s postgraduate training included an internship and residency in the Department of Surgery at Mount Sinai Hospital as well as a residency in Urology at the Squier Urologic Clinic, Columbia University. He was an American Urologic Association Scholar between 1988 – 1990 that focused on identifying molecular markers and urodynamic parameters that herald bladder and prostate dysfunction.

Currently, he is Professor of Urology at the Icahn School of Medicine at Mount Sinai and Director of Benign Urologic Diseases and The Men’s Health Program of the Mount Sinai Health System. He is a serial entrepreneur and a founder of Medidata Solutions Inc., a publicly held corporation and one of the premier electronic data capture companies in the world; Medivizor, Inc., a medical informatics enterprise; Eco – Fusion, a novel health care interface platform, Health Deck, an aggregator of heath care models using artificial intelligence; and InspiReN, a digital interface analyzing and enhancing the patient experience.

Dr. Kaplan is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He is a recognized authority on the study of benign diseases of the prostate, the association of metabolic factors and voiding dysfunction and female urology. He has published more than 1,000 articles, 170 abstracts, and has made over 340 presentations in more than 35 countries. He is the co - author of five books and is on the Editorial Board of Urology, Journal of Urology, and Urology Times.

Dr. Kaplan has been a member of more than 30 professional organizations, been awarded 5 NIH grants and has received over 13 million dollars in research funding.

Presentation(s):

Send Email for Steven Kaplan

Harris E. Foster

Yale University School of Medicine

Dr. Harris E. Foster, Jr., M.D. earned his undergraduate degree in biology from the University of Michigan at Ann Arbor. He then graduated with honors from the University of Miami School of Medicine, a member of the Alpha Omega Alpha medical honor society. Dr. Foster subsequently completed his urology residency at the University of Michigan Hospitals and joined the faculty at Yale University School of Medicine where he is currently Professor in the Department of Urology. He is also the urology residency Program Director at Yale New Haven Hospital. Dr. Foster has received grants from the National Institutes of Health (NIH) to perform clinical trials investigating the pharmacologic and phytotherapeutic treatment of BPH. He was also the chairman for many years of the NIH sponsored Interstitial Cystitis Collaborative Research Network. Dr. Foster was a member of the American Board of Urology Examination Committee and functioned as an oral board examiner for this organization. He has written numerous research publications and textbook chapters and is a reviewer for many of the major urology. Finally, Dr. Foster has been a member of the guidelines committee for the evaluation and treatment of BPH and overactive bladder (OAB) sponsored by the American Urological Association.

Presentation(s):

Send Email for Harris Foster

Kevin T. McVary

Southern Illinois University School of Medicine

Kevin T. McVary, MD, FACS, Professor of Urology at Southern Illinois University School of Medicine, Department of Surgery, Division of Urology.
Dr. Kevin T. McVary specializes in male urology problems including prostate cancer and prostatic disorders as well as BPH (enlarged prostate), and the
evaluation and treatment of sexual function and erectile dysfunction. He graduated with distinction from Northwestern University and went on to receive both his medical degree and urology residency training from Northwestern Medical School. This included a one year urology research fellowship investigating neural influences on sexual reflexes. In addition, he was granted a Riba Urology Research Fellowship.
Prior to joining SIU, Dr. McVary was on the staff of Northwestern University Feinberg School of Medicine, most recently serving as Director of the Center for Sexual Health at Northwestern Memorial Hospital, conducting the Prostate Diseases Minimally Invasive Program and directing the Andrology Fellowship Program.
An experienced investigator in prostatic disorders, andrology and erectile dysfunction, Dr. McVary is currently and has recently been principle investigator for more than 115 clinical trials including ones through the National Institute of Health. His research has generated more than 300 publications, including refereed journal articles, books, book chapters and abstracts. He currently serves at the Associate Editor of the Journal of Urology.
Dr. McVary is a member of several professional societies including the American Urological Association, American Association of Genitourinary Surgeons, Clinical Society of Genitourinary Surgeons, Sexual Medicine Society of North America, Chairman of the International Consultation on Urologic Disease and the American Society of Andrology.

Presentation(s):

Send Email for Kevin McVary

J. Kellogg Parsons

UC San Diego Moores Cancer Center

J. Kellogg Parsons, MD, MHS, is Professor of Urology and Endowed Chair in Urologic Research in the UC San Diego Department of Urology. His research focuses on clinical trials of prostate cancer and population studies of BPH and patient safety. He is a principle investigator for multi-center clinical trials funded by the National Cancer Institute, the Department of Defense, and the Prostate Cancer Foundation. He is an author on over 125 peer-reviewed publications, including papers in The New England Journal of Medicine, JAMA, JAMA Surgery, and European Urology. He is an Associate Editor at Prostate Cancer Prostatic Diseases; a consulting editor for European Urology; Vice Chair of the National Comprehensive Cancer Network (NCCN) Panel on Prostate Cancer Early Detection; and currently serves on the AUA Guidelines Panel for BPH. Dr. Parsons’ clinical practice focuses on prostate cancer and BPH. He has expertise in robotic prostatectomy (radical and simple), MRI-guided prostate biopsy, and prostate cryosurgery. He has been named to the America’s Best Doctors® and the San Diego Medical Society Top Doctors lists for several years. Dr. Parsons has an M.D. from the University of Pennsylvania and completed residency and fellowship training at the Johns Hopkins Hospital.

Presentation(s):

Send Email for J. Kellogg Parsons


Assets

044IC - AUA Guidelines 2018: Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for AUA Guidelines 2018: Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia